Translating science into sustainable solutions

Core technology is the foundation of a wide range of innovative applied products

SGI and its business units have developed key partnerships and agreements with multiple industry leaders. For more information about our business and how to partner with us, please contact our Corporate Development team at collaborations@syntheticgenomics.com.

Applied products

Creating novel solutions and transforming existing products

Health

Flu Vaccines, Gene/Cell Therapy, Biologics, Organ Transplants, Antimicrobials

Nutrition

Dietary Supplements, Food Ingredients, Omega 3 Oils, Algal Protein

Bio-Industrial

Renewable Chemicals, Bio-based Intermediates, Plant Enhancement and Protection, Algal Biofuel

 

Current Partnered Programs

ADM

Non-GMO algal omega-3 DHA

Developing products containing Omega-3 Docosahexaenoic Acid (DHA) from a non-genetically modified algae strain.

Read Case Study

ExxonMobil

Algal biofuel

SGI and ExxonMobil are focused on researching and developing naturally occurring and conventionally modified algae strains for use in developing algae-based biofuels.

Read Case Study

GSK

Multivalent RNA-based vaccines

SGI, JCVI and GSK are collaborating to develop and evaluate multivalent RNA-based vaccines for protection against a highly diverse infectious disease pathogen.

Seqirus

Rapid precision flu vaccine

SGI employed synthetic genomics tools and technologies developed by our team to accelerate the production of the influenza vaccine seeds required for vaccine manufacturing.

Read Case Study

United Therapeutics

Mammalian cell engineering

SGI and United Therapeutics have joined together to address the critical unmet organ need through xenotransplantation, the use of pigs as an essentially unlimited source of donor organs.

Read Case Study

 

Future Applications

Direct market and strategic partnership opportunities

Life Science Instruments
Biologics
Nutritional Protein
Cell Therapy
Vaccine
 
TOP